Form 4 for STE Steris
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-21 · accession 0001628280-25-054011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-25 | 2025-11-21 | STE | Madsen Julia | SVP, GM, Life Sciences | S - Sale+OE | $262.00 | -5,008 | 10.7K | -32% | -$1.31M |
| DM | 2025-11-25 | 2025-11-21 | STE | Madsen Julia | SVP, GM, Life Sciences | M - OptEx | $128.22 | +5,008 | 13.6K | +58% | +$642.1K |
| DM | 2025-11-25 | 2025-11-21 | STE | Madsen Julia | SVP, GM, Life Sciences | M - OptEx | $0.00 | -5,008 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-21 | S | D | 2,136 | $262.00 | 10,710 | D | — | — | (F1) As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |
| 2 | Common | Ordinary Shares | 2025-11-21 | M | A | 2,136 | $147.05 | 12,846 | D | — | — | (F1) As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |
| 3 | Common | Ordinary Shares | 2025-11-21 | S | D | 2,872 | $262.00 | 10,710 | D | — | — | (F1) As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |
| 4 | Common | Ordinary Shares | 2025-11-21 | M | A | 2,872 | $114.22 | 13,582 | D | — | — | (F1) As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2025-11-21 | M | D | 2,136 | $0.00 | 0 | D | $147.05 · — to 2029-05-31 | 2,136 Ordinary Shares | (F2) This option is fully vested. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2025-11-21 | M | D | 2,872 | $0.00 | 0 | D | $114.22 · — to 2028-05-31 | 2,872 Ordinary Shares | (F2) This option is fully vested. |